The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IIa safety and efficacy of milciclib, a pan-cyclin dependent kinase inhibitor, in unresectable, sorafenib-refractory or -intolerant hepatocellular carcinoma patients.
 
Erica Villa
Consulting or Advisory Role - Tiziana Life Sciences
 
Fabio Piscaglia
Consulting or Advisory Role - Tiziana Life Sciences
 
Rabit Geva
No Relationships to Disclose
 
George Dalecos
No Relationships to Disclose
 
George Papatheodoridis
No Relationships to Disclose
 
Marina Ciomei
No Relationships to Disclose
 
Christina Davite
No Relationships to Disclose
 
Patrizia Crivori
No Relationships to Disclose
 
Vaseem Palejwala
Employment - Tiziana Life Sciences
 
Jules Jacob
Employment - Tiziana Life Sciences
 
Fayez Hamzeh
Employment - Tiziana Life Sciences
 
Kunwar Shailubhai
Employment - Tiziana Life Sciences
Leadership - Tiziana Life Sciences
Stock and Other Ownership Interests - Tiziana Life Sciences
Travel, Accommodations, Expenses - Tiziana Life Sciences
Other Relationship - Tiziana Life Sciences
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Angelo Sangiovanni
Consulting or Advisory Role - Tiziana Life Sciences